2014 World In Vitro Diagnostics Industry: Market Shares and Country Forecasts for 400 Assays, 20 Market Segments and 14 Test Locations--Emerging Opportunities and Business Expansion Strategies for Suppliers
To prepare diagnostics industry executives for radically different operating climates and reduce surprises, Venture Planning Group has published a series of 10 global market research surveys, “2014 World In Vitro Diagnostics Industry:Market Shares and Country Forecasts.” The series is designed to provide industry decision-makers with strategically significant competitor information, analyses and insight crucial to the development and implementation of effective business, marketing and R&D programs. The report examines future trends in the U.S., Europe and Asia; reviews over 400 current and emerging assays; analyzes potential applications of innovative technologies; provides supplier shares and sales forecasts by assay, method, market segment, and country; profiles leading players and potential market entrants; and suggests alternative market expansion strategies for instrument and reagent suppliers. The series is based on the following studies:
Worldwide Market Overview
Strategic assessments of major diagnostic product manufactures and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D.
The companies analyzed in the report include:
The report is based on a combination of primary and secondary information sources, including questionnaire responses, as well as interviews with laboratory directors and executives of leading diagnostic companies and start-up firms developing innovative technologies and products in the U.S., Europe and Asia. In addition to primary sources of information, a comprehensive review of Venture Planning Groups proprietary database, and the most recent technical, business, manufacturer, and financial publications was conducted.
Contains approximately 9,700 pages and 3,200 tables
- Future Scenarios of the In Vitro Diagnostics Market: Technological Breakthroughs, Economic Austerity, Business-as-Usual
- 2014 Opportunities in the Global Clinical Chemistry and Immunodiagnostics: Spot Fast-Growing Market Segments Therapeutic Drug Monitoring (TDM), Endocrine Function, Tumor Markers, Special Chemistry, Immunoproteins, Drugs of Abuse
- 2014 Analysis of the Global Molecular Diagnostics Market Integrating New Technology Planning with Business and Corporate Strategies- Emerging Tests, Market Forecasts, Competitive Intelligence
- 2014 Automated Microbiology Market Molecular Diagnostics, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics
- Infectious Disease Testing: A Rapidly Growing and Challenging Market Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence
- 2014 Market Segmentation Analysis of the Global Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations
- 2014 Analysis of the Global Hematology and Flow Cytometry Markets: France, Germany, Italy, Japan, Spain, UK, USA Sales Forecasts, Supplier Shares, Competitive Strategies
- 2014 Molecular Blood Typing, Grouping and Infectious Disease NAT Market: France, Germany, Italy, Japan, Spain, UK, US--Emerging Technologies, Sales Forecasts, Supplier Shares, Competitive Strategies
- New Frontiers in Coagulation Testing: Global Challenges, Emerging Technologies, Competitive Landscape
- 2014 Analysis of the Global Point-of-Care Diagnostic Testing Market Country Segment Forecasts, Market Shares, Emerging Technologies, Competitive Strategies, Growth Opportunities
Worldwide Market Overview
- Facilities performing diagnostic tests by country.
- Test volume and sales projections by country.
- Comprehensive review of the market dynamics, trends, structure, size, growth, and key suppliers, by country.
- Test volume and sales forecasts for over 400 diagnostic procedures.
- Market segments analyzed in the report include:
- Immunodignostics
- TDM
- Endocrine Function
- Special Chemistry
- Immunoproteins
- Drugs of Abuse
- Molecular Diagnostics
- Infectious Diseases
- Cancer
- Genetic Testing
- Forensic Testing
- Paternity Testing/HLA Typing
- Microbiology
- Microbial Identification
- Antibiotic Susceptibility
- Urine Screening
- Blood Culture
- Cancer Diagnostic
- Hematology
- Flow Cytometry
- Blood Typing, Grouping, and Screening
- Coagulation Testing
- Centralized Testing Locations
- Hospitals
- Commercial/Private Laboratories
- Public Health Laboratories
- Blood Banks
- POC/Decentralized Testing Locations
- Home/Personal Testing
- Physician Offices/Group Practices
- Emergency Rooms
- Operating/Recovery Suites
- ICUs/CCUs
- Cancer Clinics
- Ambulatory Care Centers
- Surgery Centers
- Nursing Homes
- Birth Centers
- Analysis of current and emerging tests.
- Review of latest instrumentation technologies, and feature comparison of high-, medium-, and low-volume/POC analyzers.
- Assessment of current and emerging diagnostic technologies, and their potential market applications.
- Worldwide listings of companies developing or marketing new technologies and products by test.
- New product development opportunities with significant market appeal.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.
Strategic assessments of major diagnostic product manufactures and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D.
The companies analyzed in the report include:
- Abbott
- ADI/America Diagnostica
- AdnaGen
- Affymetrix
- Agilent Technologies
- Applied Gene Technologies
- Arca/Nuvelo
- Axis-Shield
- Alere/Biosite/Inverness
- Bayer Healthcare
- Beckman Coulter/Danaher
- Becton Dickinson
- Bio/Data
- Biokit
- Biomedical Diagnostics
- Biomerieux
- Bio-Rad
- Biotest
- Caliper
- Cellavision
- Cephid
- Chrono-Log
- Corgenix Medical
- Correlogic Systems/Vermillion
- Decode
- Diadexus
- Diagast
- Diagnocure
- Diagnostica Stago
- Diamedix
- Diasorin
- Eiken Chemical
- EKF Diagnostics
- Enzo Biochem
- Enterix
- Epigenomics
- Exact Sciences
- Fujirebio/Innogenetics
- Gen-Probe/Hologic
- Grifols/Novartis
- Guided Therapeutics
- Helena Laboratories
- Horiba
- Hyphen BioMed
- ID Biomedical/GSK
- Illumina
- Immucor
- International Technidyne/Nexus DX
- Instrumentation Laboratory
- Iris/Danaher
- Kreatech
- Kyowa Medex
- Li-Cor Biosciences
- Lonza
- Mackay Life Sciences
- Matritech/Alere
- Monogram Biosciences
- Myriad Genetics
- Nanogen/Elitech
- Nihon Kohden
- OncoLab
- Orchid CellMark
- Ortho-Clinical Diagnostics
- Panacea Pharmaceuticals
- Polartechnics
- Polymedco
- PreMD
- Proteome Sciences
- Qiagen/Ipsogen
- Quest Diagnostics
- Quidel
- Radiant Pharmaceuticals
- Roche
- Scienion
- SDIX
- Sequenom
- SeraCare
- Shimadzu
- Siemens
- Sienco
- Sierra Molecular
- Sysmex
- Takara Bio
- Targeted Diagnostics & Therapeutics
- Tecan Group
- Thermo Fisher/Life Technologies
- Tosoh
- Trinity Biotech
- Veridex
- Wako
- Wallac/PE
- Zycare/Alere
- Zyla
The report is based on a combination of primary and secondary information sources, including questionnaire responses, as well as interviews with laboratory directors and executives of leading diagnostic companies and start-up firms developing innovative technologies and products in the U.S., Europe and Asia. In addition to primary sources of information, a comprehensive review of Venture Planning Groups proprietary database, and the most recent technical, business, manufacturer, and financial publications was conducted.
Contains approximately 9,700 pages and 3,200 tables
I. INTRODUCTION
II. EXECUTIVE SUMMARY
III. CONCLUSIONS AND RECOMMENDATIONS
IV. THE SCENARIOS
A. Business-As-Usual Scenario
1. BUSINESS ENVIRONMENT
a. Health Care Expenditures
b. Cost-Consciousness
c. Reimbursement
d. Industry Consolidation
e. Hospitals
f. Admissions
g. Length of Stay
h. Industry Diversification
i. Physician Demographics
j. Aging Population
More Chronic Illnesses
Higher Incidence of Disease
Greater Susceptibility to Iatrogenesis
More Cases with Multiple Illnesses
2. OUTLOOK FOR THE IN VITRO DIAGNOSTICS MARKET
a. Government Regulations
b. Regulatory Reforms
c. Hospitals
d. Commercial Laboratories
e. Physician Offices
f. Point-of-Care Testing
g. Personal Testing
h. Other Testing Locations
3. Strategic Implications
a. Testing Patterns
Test Utilization
Pre-Admission Testing
Inpatient Testing
Outpatient Testing
4. MARKET SEGMENTS
a. Chemistry and Immunoassay
Introduction
Future Situation
b. Microbiology and Serology
Introduction
Future Situation
c. Hematology and Flow Cytometry
Introduction
Future Situation
d. Blood Banking
Introduction
Future Situation
e. Histology and Cytology
Introduction
Future Situation
f. Coagulation
Introduction
Future Situation
g. Urinalysis
Introduction
Future Situation
5. TECHNOLOGIES
a. Molecular Diagnostics
Introduction
Future Situation
b. Monoclonal Antibodies
Introduction
Future Situation
c. Solid Phase Chemistry
Introduction
Future Situation
d. Biosensors And Biochips
Introduction
Future Situation
e. Automation and Robotics
Introduction
Future Situation
f. IT
Introduction
Future Situation
6. The New Marketplace
a. Purchasing Influences
b. Marketing Strategies
c. Joint Venture, Merger, and Licensing Activity
d. Import-Export
e. Potential Market Entrants
f. Who May Not Survive?
B. Economic Austerity Scenario
1. BUSINESS ENVIRONMENT
a. Socio-Political Climate
Cost-Consciousness
Government Actions
Three-Tier System
Health Rationing
Voucher System
Health IRA
b. Hospital Closures
c. Hospital Utilization
d. Hospital Reorganization
e. Physician Regulations
f. Wellness Programs
g. Corporate Responses
h. Academic Research
2. OUTLOOK FOR THE IN VITRO DIAGNOSTICS MARKET
a. Test Utilization Control
Improved Ordering Practices
Better Documentation
Recertification
b. Technology Regulations
c. New Laboratory Ventures
d. IT
e. Industrial Medicine
f. Insurance Companies
g. Test Volume and Market Size
3. STRATEGIC IMPLICATIONS
a. Testing Patterns
Pre-Admission Testing
Inpatient Testing
Outpatient Testing
b. Market Segments
Chemistry and Immunoassay
Microbiology and Serology
Hematology and Flow Cytometry
Blood Banking
Histology and Cytology
Coagulation
Urinalysis
c. Technologies
Molecular Diagnostics
Monoclonal Antibodies and Immunoassays
Automation and Robotics
Solid Phase Chemistry
Biosensors And Biochips
d. The New Marketplace
Purchasing Influences
Marketing Strategies
Joint Venture, Merger, and Licensing Activity
Import-Export
Potential Market Entrants
Who May Not Survive?
C. Technological Breakthroughs Scenario
1. BUSINESS ENVIRONMENT
a. Political/Regulatory Climate
b. R & D Funding
c. Industry-Government Relationship
d. Industry-University Ventures
e. Technological Environment
f. Decentralization
g. Health Care Expenditures
h. Physician Population
i. Hospital Indicators
2. OUTLOOK FOR THE IN VITRO DIAGNOSTICS MARKET
a. Overview
b. Molecular Diagnostics
c. Monoclonal Antibodies
d. Immunoassays
e. Information Technology/Informatics
f. Laboratory Automation and Robotics
g. In Vitro-In Vivo Integration
h. Solid Phase Chemistry
i. Microarrays And Biochips
k. Pharmacogenomics
l. Pharmaceuticals
3. STRATEGIC IMPLICATIONS
a. Testing Patterns
Pre-Admission Testing
Inpatient Testing
Outpatient Testing
Test Volume and Market Size
b. Market Segments
Chemistry and Immunoassay
Microbiology and Serology
Hematology and Flow Cytometry
Blood Banking
Histology and Cytology
Coagulation
Urinalysis
c. The New Marketplace
Purchasing Influences
Marketing Strategies
Joint Venture, Merger, and Licensing Activity
Import-Export
Potential Market Entrants
Who May Not Survive?
V. METHODOLOGY
A. The Delphi
B. Cross-Impact Analysis
C. Substitution Models2014 Opportunities in the Global Clinical Chemistry and Immunodiagnostics:
Spot Fast-Growing Market Segments Therapeutic Drug Monitoring (TDM), Endocrine Function, Tumor Markers, Special Chemistry, Immunoproteins, Drugs of Abuse
I. Introduction
II. Worldwide Market and Technology Overview
A. Major Routine Chemistry Tests
B. Therapeutic Drug Monitoring (TDM)
C. Endocrine Function Tests
D. Tumor Markers And Special Chemistry Tests
E. Immunoprotein Tests
F. Drugs of Abuse
G. Instrumentation Review: Operating characteristics and features of high-, medium-, and low-volume/POC analyzers
H. Major In Vitro Diagnostic Technologies and Their Potential Applications
I. Worldwide Market Overview
1. BUSINESS ENVIRONMENT
2. MARKET STRUCTURE
3. MARKET SIZE AND GROWTH
III. France
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers' Instrument and Reagent Sales and Market Shares IV. Germany
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers' Instrument and Reagent Sales and Market Shares
V. Italy
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers' Instrument and Reagent Sales and Market Shares
VI. Japan
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers' Instrument and Reagent Sales and Market Shares
VII. Spain
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers' Instrument and Reagent Sales and Market Shares
VIII. U.K.
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers' Instrument and Reagent Sales and Market Shares
IX. U.S.A.
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers' Instrument and Reagent Sales and Market Shares
X. Major Product Development Opportunities
XI. Design Criteria for Decentralized Testing Products
XII. Alternative Market Penetration Strategies
XIII. Potential Market Entry Barriers and Risks
XIV. COMPETITIVE ASSESSMENTS
Abbott Laboratories
AdnaGen
Agilent Technologies
Beckman Coulter/Danaher
Biomedical Diagnostics
BioMerieux
Bio-Rad
DiaSorin
Eiken
Fujirebio/Innogenetics
Grifols
Instrumentation Laboratory
Kyowa Medex
Matritech/Alere
Ortho-Clinical Diagnostics
Quest Diagnostics
Roche
Siemens
Sysmex
Thermo Fisher/Life Technology
Tosoh
Wako
Wallac/PE2014 Analysis of the Global Molecular Diagnostics Market
Integrating New Technology Planning with Business and Corporate Strategies Emerging Tests, Market Forecasts, Competitive Intelligence
I. Introduction
II. Worldwide Market And Technology Overview
A. DNA Sequencing
B. DNA And RNA Probe Technology
C. Detection Technologies
D. Instrumentation Review
E. Biochips: Genosensors, Microarrays, and Labs-on-the-Chip
F. Pharmacogenomics
G. Major Applications
1. MICROBIOLOGY/INFECTIOUS DISEASES
2. CANCER TESTING
3. GENETIC DISEASES
4. FORENSIC TESTING
5. PATERNITY TESTING/HLA TYPING
6. OTHER APPLICATIONS
H. Competing/complementing Technologies
I. Worldwide Market Overview
1. BUSINESS ENVIRONMENT
2. MARKET STRUCTURE
3. MARKET SIZE AND GROWTH
III. France
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth And Major Suppliers’ Sales And Market Shares
IV. Germany
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth And Major Suppliers’ Sales And Market Shares
V. Italy
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth And Major Suppliers’ Sales And Market Shares
VI. Japan
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth And Major Suppliers’ Sales And Market Shares
VII. Spain
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth And Major Suppliers’ Sales And Market Shares
VIII. U.K.
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth And Major Suppliers’ Sales And Market Shares
IX. U.S.A.
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers’ Sales and Market Shares
X. Major Product Development Opportunities
XI. Design Criteria For Decentralized Testing Products
XII. Alternative Market Penetration Strategies
XIII. Potential Market Entry Barriers And Risks
XIV. Competitive Profiles
Abbott
Affymetrix
Agilent Technologies
Applied Gene Technologies
Arca/Nuvelo
Beckman Coulter/Danaher
Becton Dickinson
Biokit
BioMerieux
Bio-Rad
Biotest
Caliper
Cepheid
Decode
Diadexus
Eiken
Enzo
Exact Sciences
Fujirebio/Innogenetics
Grifols
Hologic/Gen-Probe
Illumina
Kreatech
Li-Cor Biosciences
Life Technologies/Thermo Fisher
Monogram Biosciences
Myriad Genetics
Nanogen/Elitech
Orchid CellMark
Ortho-Clinical Diagnostics
Proteome Sciences
Qiagen
Roche
ScienionSequenom
Shimadzu
Siemens
Sierra Molecular
Takara Bio
Tecan Group
XV. Appendixes
2014 Automated Microbiology Market: Molecular Diagnostics, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics
I. Introduction
II. Worldwide Market and Technology Overview
A. Introduction
B. Major Specimen Types
C. Test Applications
D. Major Microbiology Automated and Semiautomated Systems
E. Emerging Diagnostic Technologies
F. Global Business Environment
G. Global Market Structure
H. Global Market Size and Growth
III. France
A. Business Environment
B. Market Structure
C. Market Size, Growth and Major Supplier Sales and Market Shares
IV. Germany
A. Business Environment
B. Market Structure
C. Market Size, Growth and Major Supplier Sales and Market Shares
V. Italy
A. Business Environment
B. Market Structure
C. Market Size, Growth and Major Supplier Sales and Market Shares
VI. Japan
A. Business Environment
B. Market Structure
C. Market Size, Growth and Major Supplier Sales and Market Shares
VII. Spain
A. Business Environment
B. Market Structure
C. Market Size, Growth And Major Supplier Sales and Market Shares
VIII. U.K.
A. Business Environment
B. Market Structure
C. Market Size, Growth and Major Supplier Sales and Market Shares
IX. U.S.A.
A. Business Environment
B. Market Structure
C. Market Size, Growth and Major Supplier Sales and Market Shares
X. Major Product Development Opportunities
XI. Design Criteria for Decentralized Testing Products
XII. Alternative Market Penetration Strategies
XIII. Potential Market Entry Barriers and Risks
XIV. COMPETITIVE ASSESSMENTS
Abbott
Affymetrix
Agilent Technologies
Applied Gene Technologies
Arca/Nuvelo
Beckman Coulter/Danaher
Becton Dickinson
Biokit
bioMerieux
Bio-Rad
Biotest
Caliper
Cepheid
Decode
Diadexus
Diamedix
DiaSorin
Eiken ChemicalEnzo Biochem
Exact Sciences
Fujirebio/Innogenetics
Hologic/Gen-Probe
Illumina
ID Biomedical/GSK
Kreatech
Li-Cor Biosciences
Lonza
Monogram Biosciences
Myriad Genetics
Nanogen/Elitech
Novartis Diagnostics/Grifols
Orchid CellMark
Ortho-Clinical Diagnostics
Proteome Sciences
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Sierra Molecular
Shimadzu
Takara Bio
Tecan
Thermo Fisher/Life Technologies
Wallac/PE
Wako
Infectious Disease Testing: A Rapidly Growing and Challenging Market Facing Suppliers Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence
I. Introduction
II. Worldwide Market Overview
III. Major Product Development Opportunities
IV. Design Criteria for Decentralized Testing Products
V. Alternative Market Penetration Strategies
VI. Potential Market Entry Barriers and Risks
VII. Worldwide Overview of Major Tests, Technologies, and Instrumentation
A. Major Infectious Disease Tests
B. Instrumentation Review: Operating Characteristics, Features and Selling Princes of Leading Automated and Semiautomated Analyzers
C. Emerging Diagnostic Technologies
D. Personal Testing
VIII. France
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth, Volume by Method, and Major Suppliers’Sales and Market Shares by Test
IX. Germany
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth, Volume by Method, and Major Suppliers’Sales and Market Shares by Test
X. Italy
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth Volume by Method, and Major Suppliers’Sales and Market Shares by Test
XI. Japan
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth, Volume by Method, and Major Suppliers’Sales and Market Shares by Test
XII. Spain
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth, Volume by Method, and Major Suppliers’Sales and Market Shares by Test
XIII. U.K.
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth, Volume by Method, and Major Suppliers’Sales and Market Shares by Test
XIV. U.S.A.
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth, Volume by Method, and Major Suppliers’Sales and Market Shares by Test
XV. COMPETITIVE ASSESSMENTS
Abbott
Affymetrix
Beckman Coulter/Danaher
Becton DickinsonbioMerieux
Bio-Rad
Cepheid
Diamedix
DiaSorin
Eiken Chemical
Enzo Biochem
Fujirebio/Innogenetics
Hologic/Gen-Probe
ID Biomedical/GSK
Kreatech
Lonza
Nanogen/Elitech
Novartis Diagnostics
Ortho-Clinical Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher/Life Technologies
Wallac/PE
Wako
XVI. Appendix
2014 Market Segmentation Analysis of the Global Cancer Diagnostics Industry: Oncogenes, Bichemical Markers, Lymphokines, Gfs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations
I. Introduction
II. Worldwide Market Overview
III. Major Product Development Opportunities
IV. Design Criteria for Decentralized Testing Products
V. Alternative Market Penetration Strategies
VI. Potential Market Entry Barriers and Risks
VII. Worldwide Market and Technology Overview
A. Cancer Statistics and Etiology
B. Major Current And Emerging Cancer Diagnostic Tests
C. Biochemical Tumor Markers
D. Oncogenes
E. Polypeptide Growth Factors
1. ECTOPIC HORMONES
2. COLONY STIMULATING FACTORS
F. Lymphokines
G. Immunohistochemical Stains
H. Emerging Tumor Markers
I. Instrumentation Review And Market Needs
J. Current and Emerging Technologies
K. Personal Testing
VIII. France
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
Volume Forecasts by Test and Market Segment
Sales Forecasts by Test and Market Segment
Major Supplier Sales and Market Shares
IX. Germany
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
Volume Forecasts by Test and Market Segment
Sales Forecasts by Test and Market Segment
Major Supplier Sales and Market Shares
X. Italy
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
Volume Forecasts by Test and Market Segment
Sales Forecasts by Test and Market Segment
Major Supplier Sales and Market Shares
XI. Japan
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
Volume Forecasts by Test and Market Segment
Sales Forecasts by Test and Market Segment
Major Supplier Sales and Market Shares
XII. Spain
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
Volume Forecasts by Test and Market Segment
Sales Forecasts by Test and Market Segment
Major Supplier Sales and Market Shares
XIII. U.K.
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
Volume Forecasts by Test and Market Segment
Sales Forecasts by Test and Market Segment
Major Supplier Sales and Market Shares
XIV. U.S.A.
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
Volume Forecasts by Test and Market Segment
Sales Forecasts by Test and Market Segment
Major Supplier Sales and Market Shares
XV. Competitive Profiles
Abbott
AdnaGen
Agilent Technologies
Applied Gene Technologies
Arca/Nuvelo
Beckman Coulter/Danaher
Becton Dickinson
Biomedical Diagnostics
bioMerieux
Bio-Rad
CellSearch
Cepheid
Correlogic Systems/Vermillion
Decode
Diadexus
Diagnocure
Diasorin
Eiken Chemical
Epigenomics
Enterix
Enzo Biochem
Exact Sciences
Fujirebio/Innogenetics
Guided Therapeutics
Hologic/Gen-Probe
Kreatech
Kyowa Medex
Mackay Life Sciences
Myriad Genetics
Nanogen Elitech
OncoLab
Ortho-Clinical Diagnostics
Panacea Pharmaceuticals
Polartechnics
Polymedco
PreMD
Qiagen/Ipsogen
Quest Diagnostics
Radient Pharmaceuticals
Roche
Scienion
Sequenom
Siemens Healthcare
Takara Bio
Targeted Diagnostics & Therapeutics
Thermo Fisher/Life Technologies
Tosoh
Veridex
Wako Pure Chemicals
Wallac/PE
Zila
XVI. Appendix
2014 ANALYSIS OF THE GLOBAL HEMATOLOGY AND FLOW CYTOMETRY MARKETS: France, Germany, Italy, Japan, Spain, UK, USA Sales Forecasts, Supplier Shares, Competitive Strategies
I. Introduction
II. Worldwide Market and Technology Overview
A. Major Routine and Special Hematology Tests
1. INTRODUCTION
2. CBC ANALYSIS
3. WHITE BLOOD CELL ANALYSIS
B. Major Flow Cytometry Applications
C. Instrumentation Review
1. HEMATOLOGY ANALYZERS
2. FLOW CYTOMETERS
3. PLATELET AGGREGOMETERS
4. SEDIMENTATION RATE ANALYZERS
D. Current Market Needs and Future Demand For Hematology Analyzers
E. Reagents and Controls
F. Current and Emerging Technologies
G. Worldwide Market Overview
1. BUSINESS ENVIRONMENT
2. MARKET STRUCTURE
3. MARKET SIZE AND GROWTH
III. France
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers’ Instrument Placements, Installed Base, Sales and Market Shares
IV. Germany
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers’ Instrument Placements, Installed Base, Sales and Market Shares
V. Italy
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers’Instrument Placements, Installed Base, Sales and Market Shares
VI. Japan
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers’ Instrument Placements, Installed Base, Sales and Market Shares
VII. Spain
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers’ Instrument Placements, Installed Base, Sales and Market Shares
VIII. U.K.
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers’ Instrument Placements, Installed Base, Sales and Market Shares
IX. U.S.
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers’ Instrument Placements, Installed Base, Sales and Market Shares
X. Major Product Development Opportunities
XI. Design Criteria for Decentralized Testing Products
XII. Alternative Market Penetration Strategies
XIII. Potential Market Entry Barriers and Risks
XIV. COMPETITIVE ASSESSMENTS
Abbott
Agilent Technologies
Beckman Coulter/Danaher
Becton Dickinson
Bio-Rad
CellaVision
Horiba
Iris
Nihon Kohden
Ortho-Clinical Diagnostics
Roche
Siemens
Sysmex
XV. Appendix
2014 Molecular Blood Typing, Grouping and Infectious Disease NAT Market: France, Germany, Italy, Japan, Spain, UK, USA-Emerging Technologies, Sales Forecasts, Supplier Shares, Competitive Strategies
I. Introduction
II. Worldwide Technology and Market Overview
A. Major Blood Typing, Grouping and Infectious Disease Screening Tests
a. Blood Typing and Grouping Tests
b. Blood Group Genotyping
c. Infectious Disease Screening Tests
d. Pathogen Reduction
e. Leukocyte Reduction
B. Instrumentation Review: Operating Characteristics, Features and Selling Prices of Leading Automated And Semiautomated Analyzers
C. Major in Vitro Diagnostic Technologies And Their Potential Applications
D. Worldwide Market Overview
1. BUSINESS ENVIRONMENT
2. MARKET STRUCTURE
3. MARKET SIZE AND GROWTH
III. France
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Supplier Sales and Market Shares for Blood Typing, Grouping and Infectious Disease Screening Tests
IV. Germany
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Supplier Sales and Market Shares for Blood Typing, Grouping and Infectious Disease Screening Tests
V. Italy
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Supplier Sales and Market Shares for Blood Typing, Grouping and Infectious Disease Screening Tests
VI. Japan
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Supplier Sales and Market Shares for Blood Typing, Grouping and Infectious Disease Screening Tests
VII. Spain
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Supplier Sales and Market Shares for Blood Typing, Grouping and Infectious Disease Screening Tests
VIII. U.K.
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Supplier Sales and Market Shares for Blood Typing, Grouping
IX. U.S.A.
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Supplier Sales and Market Shares for Blood Typing, Grouping And Infectious Disease Screening Tests
X. Major Product Development Opportunities
XI. Alternative Market Penetration Strategies
XII. Potential Market Entry Barriers and Risks
XIII. COMPETITIVE ASSESSMENTS
Abbott
Beckman Coulter/Danaher
Becton Dickinson
Biokit
BioMerieux
Bio-Rad
Diagast
DiaSorin
Fujirebio/Innogenetics
Grifols/Novartis
Hologic/Gen-Probe
Immucor
Orchid CellMark
Ortho-Clinical Diagnostic
Proteome Sciences
Quest
Quidel
Roche
Siemens
Tecan
Thermo Fisher/Life Technologies
New Frontiers in Coagulation Testing: Global Challenges, Emerging Technologies, Competitive Landscape
I. Introduction
II. Worldwide Market and Technology Overview
A. Major Routine and Special Coagulation Tests
B. Instrumentation Review
C. Major in Vitro Diagnostic Technologies and Their Potential Applications
D. Worldwide Market Overview
1. BUSINESS ENVIRONMENT
2. MARKET STRUCTURE
3. MARKET SIZE AND GROWTH
4. POC TESTING MARKET
III. France
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Instrument And Reagent Suppliers’ Sales and Market Shares
IV. Germany
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Instrument And Reagent Suppliers’ Sales and Market Shares
V. Italy
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Instrument And Reagent Suppliers’ Sales and Market Shares
VI. Japan
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Instrument And Reagent Suppliers’ Sales and Market Shares
VII. Spain
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Instrument And Reagent Suppliers’ Sales and Market Shares
VIII. UK
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Instrument And Reagent Suppliers’ Sales and Market Shares
IX. USA
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth And Major Instrument And Reagent Suppliers’ Sales and Market Shares
X. Major Product Development Opportunities
XI. Design Criteria For Decentralized Testing Products
XII. Alternative Market Penetration Strategies
XIII. Potential Market Entry Barriers and Risks
XIV. COMPETITIVE ASSESSMENTS
Abbott
ADI/American Diagnostic
Axis-Shield
Alere/Biosite/Inverness Beckman Coulter/Danaher
Becton Dickinson
Bio/Data
Chrono-Log
Corgenix Medical
Diagnostica Stago/Trinity Biotech
Grifols
Helena Laboratories
HYPEN BioMed
Instrumentation Laboratory
ITC/Nexus Dx
Roche
Siemens
Sienco
Sysmex
Thermo Fischer/Life Technologies
ZyCare/Alere
2014 Analysis of the Global Point-of-Care Diagnostic Testing Market: Country Challenges, Emerging Technologies, Competitive Landscape
I. Introduction
II. Executive Summary
A. Rationale for Testing Decentralization
III. Worldwide Market and Technology Overview
B. Major Routine Chemistry Tests
C. Infectious Disease Tests
D. Tumor Markers
E. Major Routine and Special Hematology Tests
F. Endocrine Function Tests
G. Therapeutic Drug Monitoring (TDM)
H. Coagulation Tests
I. Immunoprotein Tests
J. Drugs of Abuse
K. Instrumentation
1. CHEMISTRY ANALYZERS
2. HEMATOLOGY ANALYZERS
3. COAGULATION ANALYZERS
L. Current and Emerging Technologies
M. Worldwide Business Environment
IV. U.S.A.
A. Market Overview
B. Personal Testing
1. GLUCOSE MONITORING
MARKET AND TECHNOLOGY OVERVIEW
Invasive Testing
Non-Invasive Testing
Genetic Testing
2. PREGNANCY TESTS
3. OCCULT BLOOD TESTS
4. MARKET SIZE AND GROWTH
C. Physician Offices/Group Practices
1. MARKET SUMMARY
2. MARKET STRUCTURE
3. TEST VOLUME AND SALES FORECASTS
D. Ancillary Hospital Locations
1. INTRODUCTION
a. Emergency Departments
b. Operating Suites
c. Intensive Care Units
2. EMERGENCY DEPARTMENTS
a. Market Summary
b. Test Volume and Sales Forecasts
3. OPERATING AND RECOVERY SUITES
a. Market Summary
b. Test Volume and Sales Forecasts
4. ICUS/CCUS
a. Market Summary
b. Test Volume and Sales Forecasts
E. Cancer Clinics
1. INTRODUCTION
2. MARKET SUMMARY
3. TEST VOLUME AND SALES FORECASTS
F. Ambulatory Care Centers
1. INTRODUCTION
2. MARKET SUMMARY
3. MARKET STRUCTURE
4. TEST VOLUME AND SALES FORECASTS
G. Surgery Centers
1. INTRODUCTION
2. MARKET SUMMARY
3. MARKET STRUCTURE
4. TEST VOLUME AND SALES FORECASTS
H. Nursing Homes
1. INTRODUCTION
2. MARKET SUMMARY
3. MARKET STRUCTURE
4. TEST VOLUME AND SALES FORECASTS
I. BIRTH CENTERS
1. INTRODUCTION
2. MARKET SUMMARY
3. MARKET STRUCTURE
4. TEST VOLUME AND SALES FORECASTS
J. Major Supplier Instrument Placements, Installed Base, Consumables Sales and Market Shares
V. Germany
A. Market Overview
B. Market Structure
C. Market Summary
D. Test Volume and Sales Forecasts
E. Major Suppliers’ Instrument Placements, Installed Base, Consumables Sales and Market Shares
VI. Spain
A. Business Environment
B. Market Structure
C. Market Summary
D. Test Volume and Sales Forecasts
E. Major Suppliers’ Instrument Placements, Installed Base, Consumables Sales and Market Shares
VII. Major Product Development Opportunities
VIII. Design Criteria for Decentralized Testing Products
IX. Alternative Market Penetration Strategies
X. Potential Market Entry Barriers and Risks
XI. Company Profiles
Abbott
ADI/America Diagnostica
Agilent Technologies
Axis-Shield
Beckman Coulter/Danaher
Becton Dickinson
Bio/Data
Biomerieux
Bio-RadBiosite/Inverness/Alere
Cepheid
Chrono-Log
Corgenix
Decode
Diadexus
Diagnocure
Diagnostica Stago/Trinity Biotech
Diamedix
Diasorin
Eiken Chemical
EKF Diagnostics
Fujirebio/Innogenetics
Grifols
Helena Laboratories
Hologic/Gen-Probe
Horiba
Instrumentation Laboratory
International Technidyne/Nexus DX
Kreatech
Kyowa Medex
Lonza
Mackay Life Sciences
Matritech
Nihon Kohden
Ortho-Clinical Diagnostics
Polartechnics
Polymedco
Qiagen
Roche
SDIX
Sequenom
Siemens
Sienco
Sysmex
Takara Bio
ThermoFisher/Life Technologies
Tosoh
Wako
Zycare/Alere
II. EXECUTIVE SUMMARY
III. CONCLUSIONS AND RECOMMENDATIONS
IV. THE SCENARIOS
A. Business-As-Usual Scenario
1. BUSINESS ENVIRONMENT
a. Health Care Expenditures
b. Cost-Consciousness
c. Reimbursement
d. Industry Consolidation
e. Hospitals
f. Admissions
g. Length of Stay
h. Industry Diversification
i. Physician Demographics
j. Aging Population
More Chronic Illnesses
Higher Incidence of Disease
Greater Susceptibility to Iatrogenesis
More Cases with Multiple Illnesses
2. OUTLOOK FOR THE IN VITRO DIAGNOSTICS MARKET
a. Government Regulations
b. Regulatory Reforms
c. Hospitals
d. Commercial Laboratories
e. Physician Offices
f. Point-of-Care Testing
g. Personal Testing
h. Other Testing Locations
3. Strategic Implications
a. Testing Patterns
Test Utilization
Pre-Admission Testing
Inpatient Testing
Outpatient Testing
4. MARKET SEGMENTS
a. Chemistry and Immunoassay
Introduction
Future Situation
b. Microbiology and Serology
Introduction
Future Situation
c. Hematology and Flow Cytometry
Introduction
Future Situation
d. Blood Banking
Introduction
Future Situation
e. Histology and Cytology
Introduction
Future Situation
f. Coagulation
Introduction
Future Situation
g. Urinalysis
Introduction
Future Situation
5. TECHNOLOGIES
a. Molecular Diagnostics
Introduction
Future Situation
b. Monoclonal Antibodies
Introduction
Future Situation
c. Solid Phase Chemistry
Introduction
Future Situation
d. Biosensors And Biochips
Introduction
Future Situation
e. Automation and Robotics
Introduction
Future Situation
f. IT
Introduction
Future Situation
6. The New Marketplace
a. Purchasing Influences
b. Marketing Strategies
c. Joint Venture, Merger, and Licensing Activity
d. Import-Export
e. Potential Market Entrants
f. Who May Not Survive?
B. Economic Austerity Scenario
1. BUSINESS ENVIRONMENT
a. Socio-Political Climate
Cost-Consciousness
Government Actions
Three-Tier System
Health Rationing
Voucher System
Health IRA
b. Hospital Closures
c. Hospital Utilization
d. Hospital Reorganization
e. Physician Regulations
f. Wellness Programs
g. Corporate Responses
h. Academic Research
2. OUTLOOK FOR THE IN VITRO DIAGNOSTICS MARKET
a. Test Utilization Control
Improved Ordering Practices
Better Documentation
Recertification
b. Technology Regulations
c. New Laboratory Ventures
d. IT
e. Industrial Medicine
f. Insurance Companies
g. Test Volume and Market Size
3. STRATEGIC IMPLICATIONS
a. Testing Patterns
Pre-Admission Testing
Inpatient Testing
Outpatient Testing
b. Market Segments
Chemistry and Immunoassay
Microbiology and Serology
Hematology and Flow Cytometry
Blood Banking
Histology and Cytology
Coagulation
Urinalysis
c. Technologies
Molecular Diagnostics
Monoclonal Antibodies and Immunoassays
Automation and Robotics
Solid Phase Chemistry
Biosensors And Biochips
d. The New Marketplace
Purchasing Influences
Marketing Strategies
Joint Venture, Merger, and Licensing Activity
Import-Export
Potential Market Entrants
Who May Not Survive?
C. Technological Breakthroughs Scenario
1. BUSINESS ENVIRONMENT
a. Political/Regulatory Climate
b. R & D Funding
c. Industry-Government Relationship
d. Industry-University Ventures
e. Technological Environment
f. Decentralization
g. Health Care Expenditures
h. Physician Population
i. Hospital Indicators
2. OUTLOOK FOR THE IN VITRO DIAGNOSTICS MARKET
a. Overview
b. Molecular Diagnostics
c. Monoclonal Antibodies
d. Immunoassays
e. Information Technology/Informatics
f. Laboratory Automation and Robotics
g. In Vitro-In Vivo Integration
h. Solid Phase Chemistry
i. Microarrays And Biochips
k. Pharmacogenomics
l. Pharmaceuticals
3. STRATEGIC IMPLICATIONS
a. Testing Patterns
Pre-Admission Testing
Inpatient Testing
Outpatient Testing
Test Volume and Market Size
b. Market Segments
Chemistry and Immunoassay
Microbiology and Serology
Hematology and Flow Cytometry
Blood Banking
Histology and Cytology
Coagulation
Urinalysis
c. The New Marketplace
Purchasing Influences
Marketing Strategies
Joint Venture, Merger, and Licensing Activity
Import-Export
Potential Market Entrants
Who May Not Survive?
V. METHODOLOGY
A. The Delphi
B. Cross-Impact Analysis
C. Substitution Models2014 Opportunities in the Global Clinical Chemistry and Immunodiagnostics:
Spot Fast-Growing Market Segments Therapeutic Drug Monitoring (TDM), Endocrine Function, Tumor Markers, Special Chemistry, Immunoproteins, Drugs of Abuse
I. Introduction
II. Worldwide Market and Technology Overview
A. Major Routine Chemistry Tests
B. Therapeutic Drug Monitoring (TDM)
C. Endocrine Function Tests
D. Tumor Markers And Special Chemistry Tests
E. Immunoprotein Tests
F. Drugs of Abuse
G. Instrumentation Review: Operating characteristics and features of high-, medium-, and low-volume/POC analyzers
H. Major In Vitro Diagnostic Technologies and Their Potential Applications
I. Worldwide Market Overview
1. BUSINESS ENVIRONMENT
2. MARKET STRUCTURE
3. MARKET SIZE AND GROWTH
III. France
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers' Instrument and Reagent Sales and Market Shares IV. Germany
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers' Instrument and Reagent Sales and Market Shares
V. Italy
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers' Instrument and Reagent Sales and Market Shares
VI. Japan
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers' Instrument and Reagent Sales and Market Shares
VII. Spain
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers' Instrument and Reagent Sales and Market Shares
VIII. U.K.
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers' Instrument and Reagent Sales and Market Shares
IX. U.S.A.
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers' Instrument and Reagent Sales and Market Shares
X. Major Product Development Opportunities
XI. Design Criteria for Decentralized Testing Products
XII. Alternative Market Penetration Strategies
XIII. Potential Market Entry Barriers and Risks
XIV. COMPETITIVE ASSESSMENTS
Abbott Laboratories
AdnaGen
Agilent Technologies
Beckman Coulter/Danaher
Biomedical Diagnostics
BioMerieux
Bio-Rad
DiaSorin
Eiken
Fujirebio/Innogenetics
Grifols
Instrumentation Laboratory
Kyowa Medex
Matritech/Alere
Ortho-Clinical Diagnostics
Quest Diagnostics
Roche
Siemens
Sysmex
Thermo Fisher/Life Technology
Tosoh
Wako
Wallac/PE2014 Analysis of the Global Molecular Diagnostics Market
Integrating New Technology Planning with Business and Corporate Strategies Emerging Tests, Market Forecasts, Competitive Intelligence
I. Introduction
II. Worldwide Market And Technology Overview
A. DNA Sequencing
B. DNA And RNA Probe Technology
C. Detection Technologies
D. Instrumentation Review
E. Biochips: Genosensors, Microarrays, and Labs-on-the-Chip
F. Pharmacogenomics
G. Major Applications
1. MICROBIOLOGY/INFECTIOUS DISEASES
2. CANCER TESTING
3. GENETIC DISEASES
4. FORENSIC TESTING
5. PATERNITY TESTING/HLA TYPING
6. OTHER APPLICATIONS
H. Competing/complementing Technologies
I. Worldwide Market Overview
1. BUSINESS ENVIRONMENT
2. MARKET STRUCTURE
3. MARKET SIZE AND GROWTH
III. France
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth And Major Suppliers’ Sales And Market Shares
IV. Germany
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth And Major Suppliers’ Sales And Market Shares
V. Italy
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth And Major Suppliers’ Sales And Market Shares
VI. Japan
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth And Major Suppliers’ Sales And Market Shares
VII. Spain
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth And Major Suppliers’ Sales And Market Shares
VIII. U.K.
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth And Major Suppliers’ Sales And Market Shares
IX. U.S.A.
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers’ Sales and Market Shares
X. Major Product Development Opportunities
XI. Design Criteria For Decentralized Testing Products
XII. Alternative Market Penetration Strategies
XIII. Potential Market Entry Barriers And Risks
XIV. Competitive Profiles
Abbott
Affymetrix
Agilent Technologies
Applied Gene Technologies
Arca/Nuvelo
Beckman Coulter/Danaher
Becton Dickinson
Biokit
BioMerieux
Bio-Rad
Biotest
Caliper
Cepheid
Decode
Diadexus
Eiken
Enzo
Exact Sciences
Fujirebio/Innogenetics
Grifols
Hologic/Gen-Probe
Illumina
Kreatech
Li-Cor Biosciences
Life Technologies/Thermo Fisher
Monogram Biosciences
Myriad Genetics
Nanogen/Elitech
Orchid CellMark
Ortho-Clinical Diagnostics
Proteome Sciences
Qiagen
Roche
ScienionSequenom
Shimadzu
Siemens
Sierra Molecular
Takara Bio
Tecan Group
XV. Appendixes
2014 Automated Microbiology Market: Molecular Diagnostics, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics
I. Introduction
II. Worldwide Market and Technology Overview
A. Introduction
B. Major Specimen Types
C. Test Applications
D. Major Microbiology Automated and Semiautomated Systems
E. Emerging Diagnostic Technologies
F. Global Business Environment
G. Global Market Structure
H. Global Market Size and Growth
III. France
A. Business Environment
B. Market Structure
C. Market Size, Growth and Major Supplier Sales and Market Shares
IV. Germany
A. Business Environment
B. Market Structure
C. Market Size, Growth and Major Supplier Sales and Market Shares
V. Italy
A. Business Environment
B. Market Structure
C. Market Size, Growth and Major Supplier Sales and Market Shares
VI. Japan
A. Business Environment
B. Market Structure
C. Market Size, Growth and Major Supplier Sales and Market Shares
VII. Spain
A. Business Environment
B. Market Structure
C. Market Size, Growth And Major Supplier Sales and Market Shares
VIII. U.K.
A. Business Environment
B. Market Structure
C. Market Size, Growth and Major Supplier Sales and Market Shares
IX. U.S.A.
A. Business Environment
B. Market Structure
C. Market Size, Growth and Major Supplier Sales and Market Shares
X. Major Product Development Opportunities
XI. Design Criteria for Decentralized Testing Products
XII. Alternative Market Penetration Strategies
XIII. Potential Market Entry Barriers and Risks
XIV. COMPETITIVE ASSESSMENTS
Abbott
Affymetrix
Agilent Technologies
Applied Gene Technologies
Arca/Nuvelo
Beckman Coulter/Danaher
Becton Dickinson
Biokit
bioMerieux
Bio-Rad
Biotest
Caliper
Cepheid
Decode
Diadexus
Diamedix
DiaSorin
Eiken ChemicalEnzo Biochem
Exact Sciences
Fujirebio/Innogenetics
Hologic/Gen-Probe
Illumina
ID Biomedical/GSK
Kreatech
Li-Cor Biosciences
Lonza
Monogram Biosciences
Myriad Genetics
Nanogen/Elitech
Novartis Diagnostics/Grifols
Orchid CellMark
Ortho-Clinical Diagnostics
Proteome Sciences
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Sierra Molecular
Shimadzu
Takara Bio
Tecan
Thermo Fisher/Life Technologies
Wallac/PE
Wako
Infectious Disease Testing: A Rapidly Growing and Challenging Market Facing Suppliers Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence
I. Introduction
II. Worldwide Market Overview
III. Major Product Development Opportunities
IV. Design Criteria for Decentralized Testing Products
V. Alternative Market Penetration Strategies
VI. Potential Market Entry Barriers and Risks
VII. Worldwide Overview of Major Tests, Technologies, and Instrumentation
A. Major Infectious Disease Tests
B. Instrumentation Review: Operating Characteristics, Features and Selling Princes of Leading Automated and Semiautomated Analyzers
C. Emerging Diagnostic Technologies
D. Personal Testing
VIII. France
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth, Volume by Method, and Major Suppliers’Sales and Market Shares by Test
IX. Germany
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth, Volume by Method, and Major Suppliers’Sales and Market Shares by Test
X. Italy
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth Volume by Method, and Major Suppliers’Sales and Market Shares by Test
XI. Japan
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth, Volume by Method, and Major Suppliers’Sales and Market Shares by Test
XII. Spain
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth, Volume by Method, and Major Suppliers’Sales and Market Shares by Test
XIII. U.K.
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth, Volume by Method, and Major Suppliers’Sales and Market Shares by Test
XIV. U.S.A.
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth, Volume by Method, and Major Suppliers’Sales and Market Shares by Test
XV. COMPETITIVE ASSESSMENTS
Abbott
Affymetrix
Beckman Coulter/Danaher
Becton DickinsonbioMerieux
Bio-Rad
Cepheid
Diamedix
DiaSorin
Eiken Chemical
Enzo Biochem
Fujirebio/Innogenetics
Hologic/Gen-Probe
ID Biomedical/GSK
Kreatech
Lonza
Nanogen/Elitech
Novartis Diagnostics
Ortho-Clinical Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher/Life Technologies
Wallac/PE
Wako
XVI. Appendix
2014 Market Segmentation Analysis of the Global Cancer Diagnostics Industry: Oncogenes, Bichemical Markers, Lymphokines, Gfs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations
I. Introduction
II. Worldwide Market Overview
III. Major Product Development Opportunities
IV. Design Criteria for Decentralized Testing Products
V. Alternative Market Penetration Strategies
VI. Potential Market Entry Barriers and Risks
VII. Worldwide Market and Technology Overview
A. Cancer Statistics and Etiology
B. Major Current And Emerging Cancer Diagnostic Tests
C. Biochemical Tumor Markers
D. Oncogenes
E. Polypeptide Growth Factors
1. ECTOPIC HORMONES
2. COLONY STIMULATING FACTORS
F. Lymphokines
G. Immunohistochemical Stains
H. Emerging Tumor Markers
I. Instrumentation Review And Market Needs
J. Current and Emerging Technologies
K. Personal Testing
VIII. France
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
Volume Forecasts by Test and Market Segment
Sales Forecasts by Test and Market Segment
Major Supplier Sales and Market Shares
IX. Germany
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
Volume Forecasts by Test and Market Segment
Sales Forecasts by Test and Market Segment
Major Supplier Sales and Market Shares
X. Italy
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
Volume Forecasts by Test and Market Segment
Sales Forecasts by Test and Market Segment
Major Supplier Sales and Market Shares
XI. Japan
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
Volume Forecasts by Test and Market Segment
Sales Forecasts by Test and Market Segment
Major Supplier Sales and Market Shares
XII. Spain
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
Volume Forecasts by Test and Market Segment
Sales Forecasts by Test and Market Segment
Major Supplier Sales and Market Shares
XIII. U.K.
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
Volume Forecasts by Test and Market Segment
Sales Forecasts by Test and Market Segment
Major Supplier Sales and Market Shares
XIV. U.S.A.
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
Volume Forecasts by Test and Market Segment
Sales Forecasts by Test and Market Segment
Major Supplier Sales and Market Shares
XV. Competitive Profiles
Abbott
AdnaGen
Agilent Technologies
Applied Gene Technologies
Arca/Nuvelo
Beckman Coulter/Danaher
Becton Dickinson
Biomedical Diagnostics
bioMerieux
Bio-Rad
CellSearch
Cepheid
Correlogic Systems/Vermillion
Decode
Diadexus
Diagnocure
Diasorin
Eiken Chemical
Epigenomics
Enterix
Enzo Biochem
Exact Sciences
Fujirebio/Innogenetics
Guided Therapeutics
Hologic/Gen-Probe
Kreatech
Kyowa Medex
Mackay Life Sciences
Myriad Genetics
Nanogen Elitech
OncoLab
Ortho-Clinical Diagnostics
Panacea Pharmaceuticals
Polartechnics
Polymedco
PreMD
Qiagen/Ipsogen
Quest Diagnostics
Radient Pharmaceuticals
Roche
Scienion
Sequenom
Siemens Healthcare
Takara Bio
Targeted Diagnostics & Therapeutics
Thermo Fisher/Life Technologies
Tosoh
Veridex
Wako Pure Chemicals
Wallac/PE
Zila
XVI. Appendix
2014 ANALYSIS OF THE GLOBAL HEMATOLOGY AND FLOW CYTOMETRY MARKETS: France, Germany, Italy, Japan, Spain, UK, USA Sales Forecasts, Supplier Shares, Competitive Strategies
I. Introduction
II. Worldwide Market and Technology Overview
A. Major Routine and Special Hematology Tests
1. INTRODUCTION
2. CBC ANALYSIS
3. WHITE BLOOD CELL ANALYSIS
B. Major Flow Cytometry Applications
C. Instrumentation Review
1. HEMATOLOGY ANALYZERS
2. FLOW CYTOMETERS
3. PLATELET AGGREGOMETERS
4. SEDIMENTATION RATE ANALYZERS
D. Current Market Needs and Future Demand For Hematology Analyzers
E. Reagents and Controls
F. Current and Emerging Technologies
G. Worldwide Market Overview
1. BUSINESS ENVIRONMENT
2. MARKET STRUCTURE
3. MARKET SIZE AND GROWTH
III. France
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers’ Instrument Placements, Installed Base, Sales and Market Shares
IV. Germany
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers’ Instrument Placements, Installed Base, Sales and Market Shares
V. Italy
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers’Instrument Placements, Installed Base, Sales and Market Shares
VI. Japan
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers’ Instrument Placements, Installed Base, Sales and Market Shares
VII. Spain
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers’ Instrument Placements, Installed Base, Sales and Market Shares
VIII. U.K.
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers’ Instrument Placements, Installed Base, Sales and Market Shares
IX. U.S.
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers’ Instrument Placements, Installed Base, Sales and Market Shares
X. Major Product Development Opportunities
XI. Design Criteria for Decentralized Testing Products
XII. Alternative Market Penetration Strategies
XIII. Potential Market Entry Barriers and Risks
XIV. COMPETITIVE ASSESSMENTS
Abbott
Agilent Technologies
Beckman Coulter/Danaher
Becton Dickinson
Bio-Rad
CellaVision
Horiba
Iris
Nihon Kohden
Ortho-Clinical Diagnostics
Roche
Siemens
Sysmex
XV. Appendix
2014 Molecular Blood Typing, Grouping and Infectious Disease NAT Market: France, Germany, Italy, Japan, Spain, UK, USA-Emerging Technologies, Sales Forecasts, Supplier Shares, Competitive Strategies
I. Introduction
II. Worldwide Technology and Market Overview
A. Major Blood Typing, Grouping and Infectious Disease Screening Tests
a. Blood Typing and Grouping Tests
b. Blood Group Genotyping
c. Infectious Disease Screening Tests
d. Pathogen Reduction
e. Leukocyte Reduction
B. Instrumentation Review: Operating Characteristics, Features and Selling Prices of Leading Automated And Semiautomated Analyzers
C. Major in Vitro Diagnostic Technologies And Their Potential Applications
D. Worldwide Market Overview
1. BUSINESS ENVIRONMENT
2. MARKET STRUCTURE
3. MARKET SIZE AND GROWTH
III. France
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Supplier Sales and Market Shares for Blood Typing, Grouping and Infectious Disease Screening Tests
IV. Germany
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Supplier Sales and Market Shares for Blood Typing, Grouping and Infectious Disease Screening Tests
V. Italy
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Supplier Sales and Market Shares for Blood Typing, Grouping and Infectious Disease Screening Tests
VI. Japan
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Supplier Sales and Market Shares for Blood Typing, Grouping and Infectious Disease Screening Tests
VII. Spain
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Supplier Sales and Market Shares for Blood Typing, Grouping and Infectious Disease Screening Tests
VIII. U.K.
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Supplier Sales and Market Shares for Blood Typing, Grouping
IX. U.S.A.
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Supplier Sales and Market Shares for Blood Typing, Grouping And Infectious Disease Screening Tests
X. Major Product Development Opportunities
XI. Alternative Market Penetration Strategies
XII. Potential Market Entry Barriers and Risks
XIII. COMPETITIVE ASSESSMENTS
Abbott
Beckman Coulter/Danaher
Becton Dickinson
Biokit
BioMerieux
Bio-Rad
Diagast
DiaSorin
Fujirebio/Innogenetics
Grifols/Novartis
Hologic/Gen-Probe
Immucor
Orchid CellMark
Ortho-Clinical Diagnostic
Proteome Sciences
Quest
Quidel
Roche
Siemens
Tecan
Thermo Fisher/Life Technologies
New Frontiers in Coagulation Testing: Global Challenges, Emerging Technologies, Competitive Landscape
I. Introduction
II. Worldwide Market and Technology Overview
A. Major Routine and Special Coagulation Tests
B. Instrumentation Review
C. Major in Vitro Diagnostic Technologies and Their Potential Applications
D. Worldwide Market Overview
1. BUSINESS ENVIRONMENT
2. MARKET STRUCTURE
3. MARKET SIZE AND GROWTH
4. POC TESTING MARKET
III. France
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Instrument And Reagent Suppliers’ Sales and Market Shares
IV. Germany
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Instrument And Reagent Suppliers’ Sales and Market Shares
V. Italy
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Instrument And Reagent Suppliers’ Sales and Market Shares
VI. Japan
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Instrument And Reagent Suppliers’ Sales and Market Shares
VII. Spain
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Instrument And Reagent Suppliers’ Sales and Market Shares
VIII. UK
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Instrument And Reagent Suppliers’ Sales and Market Shares
IX. USA
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth And Major Instrument And Reagent Suppliers’ Sales and Market Shares
X. Major Product Development Opportunities
XI. Design Criteria For Decentralized Testing Products
XII. Alternative Market Penetration Strategies
XIII. Potential Market Entry Barriers and Risks
XIV. COMPETITIVE ASSESSMENTS
Abbott
ADI/American Diagnostic
Axis-Shield
Alere/Biosite/Inverness Beckman Coulter/Danaher
Becton Dickinson
Bio/Data
Chrono-Log
Corgenix Medical
Diagnostica Stago/Trinity Biotech
Grifols
Helena Laboratories
HYPEN BioMed
Instrumentation Laboratory
ITC/Nexus Dx
Roche
Siemens
Sienco
Sysmex
Thermo Fischer/Life Technologies
ZyCare/Alere
2014 Analysis of the Global Point-of-Care Diagnostic Testing Market: Country Challenges, Emerging Technologies, Competitive Landscape
I. Introduction
II. Executive Summary
A. Rationale for Testing Decentralization
III. Worldwide Market and Technology Overview
B. Major Routine Chemistry Tests
C. Infectious Disease Tests
D. Tumor Markers
E. Major Routine and Special Hematology Tests
F. Endocrine Function Tests
G. Therapeutic Drug Monitoring (TDM)
H. Coagulation Tests
I. Immunoprotein Tests
J. Drugs of Abuse
K. Instrumentation
1. CHEMISTRY ANALYZERS
2. HEMATOLOGY ANALYZERS
3. COAGULATION ANALYZERS
L. Current and Emerging Technologies
M. Worldwide Business Environment
IV. U.S.A.
A. Market Overview
B. Personal Testing
1. GLUCOSE MONITORING
MARKET AND TECHNOLOGY OVERVIEW
Invasive Testing
Non-Invasive Testing
Genetic Testing
2. PREGNANCY TESTS
3. OCCULT BLOOD TESTS
4. MARKET SIZE AND GROWTH
C. Physician Offices/Group Practices
1. MARKET SUMMARY
2. MARKET STRUCTURE
3. TEST VOLUME AND SALES FORECASTS
D. Ancillary Hospital Locations
1. INTRODUCTION
a. Emergency Departments
b. Operating Suites
c. Intensive Care Units
2. EMERGENCY DEPARTMENTS
a. Market Summary
b. Test Volume and Sales Forecasts
3. OPERATING AND RECOVERY SUITES
a. Market Summary
b. Test Volume and Sales Forecasts
4. ICUS/CCUS
a. Market Summary
b. Test Volume and Sales Forecasts
E. Cancer Clinics
1. INTRODUCTION
2. MARKET SUMMARY
3. TEST VOLUME AND SALES FORECASTS
F. Ambulatory Care Centers
1. INTRODUCTION
2. MARKET SUMMARY
3. MARKET STRUCTURE
4. TEST VOLUME AND SALES FORECASTS
G. Surgery Centers
1. INTRODUCTION
2. MARKET SUMMARY
3. MARKET STRUCTURE
4. TEST VOLUME AND SALES FORECASTS
H. Nursing Homes
1. INTRODUCTION
2. MARKET SUMMARY
3. MARKET STRUCTURE
4. TEST VOLUME AND SALES FORECASTS
I. BIRTH CENTERS
1. INTRODUCTION
2. MARKET SUMMARY
3. MARKET STRUCTURE
4. TEST VOLUME AND SALES FORECASTS
J. Major Supplier Instrument Placements, Installed Base, Consumables Sales and Market Shares
V. Germany
A. Market Overview
B. Market Structure
C. Market Summary
D. Test Volume and Sales Forecasts
E. Major Suppliers’ Instrument Placements, Installed Base, Consumables Sales and Market Shares
VI. Spain
A. Business Environment
B. Market Structure
C. Market Summary
D. Test Volume and Sales Forecasts
E. Major Suppliers’ Instrument Placements, Installed Base, Consumables Sales and Market Shares
VII. Major Product Development Opportunities
VIII. Design Criteria for Decentralized Testing Products
IX. Alternative Market Penetration Strategies
X. Potential Market Entry Barriers and Risks
XI. Company Profiles
Abbott
ADI/America Diagnostica
Agilent Technologies
Axis-Shield
Beckman Coulter/Danaher
Becton Dickinson
Bio/Data
Biomerieux
Bio-RadBiosite/Inverness/Alere
Cepheid
Chrono-Log
Corgenix
Decode
Diadexus
Diagnocure
Diagnostica Stago/Trinity Biotech
Diamedix
Diasorin
Eiken Chemical
EKF Diagnostics
Fujirebio/Innogenetics
Grifols
Helena Laboratories
Hologic/Gen-Probe
Horiba
Instrumentation Laboratory
International Technidyne/Nexus DX
Kreatech
Kyowa Medex
Lonza
Mackay Life Sciences
Matritech
Nihon Kohden
Ortho-Clinical Diagnostics
Polartechnics
Polymedco
Qiagen
Roche
SDIX
Sequenom
Siemens
Sienco
Sysmex
Takara Bio
ThermoFisher/Life Technologies
Tosoh
Wako
Zycare/Alere
